NCT05420948 2026-04-09
A Study of Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer
University of Chicago
Phase 2 Suspended
University of Chicago
University of Oklahoma
Mitra RxDx, Inc.
Queensland Centre of Excellence for Head and Neck Cancer